Annual report
2802.TEDINET S100TNWR
Period2023-04-01 → 2024-03-31
Filed2024-06-25
StandardIFRS
ConsolidatedYes
Data checks19 of 19 passed
Key figures · 154
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.44T | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.36T | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.15T | 2021-04-01 → 2022-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.07T | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.10T | 2019-04-01 → 2020-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥146.7bn | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥148.9bn | 2022-04-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥142.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥140.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥122.5bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥98.3bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥48.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥87.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥94.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥75.7bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥59.4bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥18.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥102.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥100.2bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥1.77T | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.51T | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.46T | at 2022-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.43T | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.35T | at 2020-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥890.4bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥688.8bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥884.1bn | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥823.0bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥739.7bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥814.7bn | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥768.7bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥171.5bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥132.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥151.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥181.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥141.7bn | at 2020-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥168.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥117.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥145.6bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥165.7bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥114.9bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥132.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥30.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥61.6bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥66.2bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥66.7bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥6.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥111.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥123.1bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥60.4bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥52.3bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥167.44 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥175.97 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥139.42 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥108.36 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥34.37 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥167.4 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥175.96 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥139.42 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥108.32 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥34.35 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥1,589.43 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,452.24 | at 2023-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,280.5 | at 2022-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,130.82 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥983.19 | at 2020-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 45.9% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 50.8% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 47.1% | at 2022-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 43.3% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 39.8% | at 2020-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 11.0% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 12.9% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 11.6% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 10.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 3.3% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 34,862 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 34,615 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 34,198 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 33,461 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 32,509 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥307.3bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥294.3bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥271.5bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥250.3bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥261.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥7.9bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | −¥15.6bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥150.1bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥101.1bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥83.4bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥36.3bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥36.6bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥146.9bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥108.6bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥139.7bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥107.2bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥89.2bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥37.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥8.5bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.13T | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥973.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥961.0bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥984.4bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥975.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥726.9bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥580.8bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥405.1bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥393.2bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥347.2bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥323.9bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥300.2bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥32.6bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.0bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥268.52 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥200.64 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥164.18 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.61 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.49 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥268.47 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥200.62 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥164.17 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥68.59 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥15.48 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥74 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥68 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥52 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥42 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥32 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥790.28 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥742.78 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥647.29 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥590.55 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥547.64 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 35.8% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.4% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.9% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 35.0% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 29.0% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.6% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.7% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 521,430,854 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 529,798,154 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 536,996,254 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 549,163,354 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 549,163,354 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 3,480 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 3,335 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 3,252 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 3,184 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 3,401 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-03-31 | 1111 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥102.2bn |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥3.3bn |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥345.9bn |
| Frozen Foodsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥8.8bn |
| Frozen Foodsreportable segment | employees | at 2024-03-31 | 5611 pure |
| Frozen Foodsreportable segment | segment assets | at 2024-03-31 | ¥210.0bn |
| Healthcare And Othersreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥122.4bn |
| Healthcare And Othersreportable segment | employees | at 2024-03-31 | 5351 pure |
| Healthcare And Othersreportable segment | segment assets | at 2024-03-31 | ¥469.4bn |
| Seasonings And Foodsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥33.6bn |
| Seasonings And Foodsreportable segment | employees | at 2024-03-31 | 22075 pure |
| Seasonings And Foodsreportable segment | segment assets | at 2024-03-31 | ¥646.9bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥165.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥1.43T |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-04-01 → 2023-03-31 | ¥789m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥90.0bn |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥3.8bn |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥283.6bn |
| Frozen Foodsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥11.5bn |
| Frozen Foodsreportable segment | segment assets | at 2023-03-31 | ¥200.4bn |
| Healthcare And Othersreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥24.6bn |
| Healthcare And Othersreportable segment | segment assets | at 2023-03-31 | ¥337.4bn |
| Seasonings And Foodsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥29.2bn |
| Seasonings And Foodsreportable segment | segment assets | at 2023-03-31 | ¥600.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥66.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥1.23T |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-03-31 | 106 pure |
| Frozen Foodsreportable segment | employees | at 2024-03-31 | 34 pure |
| Healthcare And Othersreportable segment | employees | at 2024-03-31 | 1000 pure |
| Seasonings And Foodsreportable segment | employees | at 2024-03-31 | 1626 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,444
| Item | Context | Value | Unit |
|---|---|---|---|
| Business profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E00436-000SeasoningsAndFoodsReportableSegmentMember | 111550000000 | JPY |
| Business profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E00436-000FrozenFoodsReportableSegmentMember | 9576000000 | JPY |
| Business profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E00436-000HealthcareAndOthersReportableSegmentMember | 24386000000 | JPY |
| Business profit loss IFRS | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2167000000 | JPY |
| Business profit loss IFRS | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 147681000000 | JPY |
| Business profit loss IFRS | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Business profit loss IFRS | CurrentYearDuration | 147681000000 | JPY |
| Other operating income IFRS | CurrentYearDuration | 20487000000 | JPY |
| Other operating expenses IFRS | CurrentYearDuration | 21486000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration | 146682000000 | JPY |
| Finance income IFRS | CurrentYearDuration | 7775000000 | JPY |
| Finance costs IFRS | CurrentYearDuration | 12414000000 | JPY |
| Profit loss before tax IFRS | CurrentYearDuration | 142043000000 | JPY |
| Depreciation and amortization operating expenses IFRS | Prior1YearDuration_jpcrp030000-asr_E00436-000SeasoningsAndFoodsReportableSegmentMember | 34187000000 | JPY |
| Depreciation and amortization operating expenses IFRS | Prior1YearDuration_jpcrp030000-asr_E00436-000FrozenFoodsReportableSegmentMember | 12710000000 | JPY |
| Depreciation and amortization operating expenses IFRS | Prior1YearDuration_jpcrp030000-asr_E00436-000HealthcareAndOthersReportableSegmentMember | 16686000000 | JPY |
| Depreciation and amortization operating expenses IFRS | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 959000000 | JPY |
| Depreciation and amortization operating expenses IFRS | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 64543000000 | JPY |
| Depreciation and amortization operating expenses IFRS | Prior1YearDuration_ReconcilingItemsMember | 7276000000 | JPY |
| Depreciation and amortization operating expenses IFRS | Prior1YearDuration | 71820000000 | JPY |
| Impairment losses pl IFRS | Prior1YearDuration_jpcrp030000-asr_E00436-000SeasoningsAndFoodsReportableSegmentMember | 1394000000 | JPY |
| Impairment losses pl IFRS | Prior1YearDuration_jpcrp030000-asr_E00436-000FrozenFoodsReportableSegmentMember | 13748000000 | JPY |
| Impairment losses pl IFRS | Prior1YearDuration_jpcrp030000-asr_E00436-000HealthcareAndOthersReportableSegmentMember | － | JPY |
| Impairment losses pl IFRS | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Impairment losses pl IFRS | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 15143000000 | JPY |
| Impairment losses pl IFRS | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Impairment losses pl IFRS | Prior1YearDuration | 15143000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E00436-000SeasoningsAndFoodsReportableSegmentMember | 37090000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E00436-000FrozenFoodsReportableSegmentMember | 13766000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E00436-000HealthcareAndOthersReportableSegmentMember | 19785000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 810000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 71453000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_ReconcilingItemsMember | 6844000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration | 78298000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00436-000SeasoningsAndFoodsReportableSegmentMember | 917000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00436-000FrozenFoodsReportableSegmentMember | 109000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00436-000HealthcareAndOthersReportableSegmentMember | 2409000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 300000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 3736000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Impairment losses pl IFRS | CurrentYearDuration | 3736000000 | JPY |
| Assets IFRS | Prior1YearInstant_jpcrp030000-asr_E00436-000SeasoningsAndFoodsReportableSegmentMember | 600312000000 | JPY |
| Assets IFRS | Prior1YearInstant_jpcrp030000-asr_E00436-000FrozenFoodsReportableSegmentMember | 200384000000 | JPY |
| Assets IFRS | Prior1YearInstant_jpcrp030000-asr_E00436-000HealthcareAndOthersReportableSegmentMember | 337394000000 | JPY |
| Assets IFRS | Prior1YearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 90046000000 | JPY |
| Assets IFRS | Prior1YearInstant_TotalOfReportableSegmentsAndOthersMember | 1228137000000 | JPY |
| Assets IFRS | Prior1YearInstant_ReconcilingItemsMember | 283597000000 | JPY |
| Assets IFRS | Prior1YearInstant | 1511734000000 | JPY |
| Investments accounted for using equity method IFRS | Prior1YearInstant_jpcrp030000-asr_E00436-000SeasoningsAndFoodsReportableSegmentMember | 48380000000 | JPY |
| Investments accounted for using equity method IFRS | Prior1YearInstant_jpcrp030000-asr_E00436-000FrozenFoodsReportableSegmentMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 19 of 19 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |